期刊文献+

基于两阶段划分的中药市场供需关系研究 被引量:7

Study on supply and demand relation based on two stages division of market of Chinese materia medica
原文传递
导出
摘要 中药市场生产环节多、产业链条长,导致中药市场微观结构研究困难。该文在界定概念之间逻辑关系的基础上将中药市场拆分为中药资源市场和中药药品市场2个阶段,并在此基础上研究了中药市场供给方的供给能力,进入规则,激励机制等;分析了中药市场需求方的需求概况,从人口、收入、保险进行了购买力评估;分析了中药市场2个阶段的价格形成机制;分析了中药药品市场竞争,中药市场属于低集中度、寡占型市场,各科室用药集中度不同,平均CR8为57.35%。通过该研究对促进中药市场相关研究的深入有积极意义。 The complex production processes and long industrial chain in traditional Chinese medicine (TCM) market result in difficulty in Chinese market microstructure research. Based on the defining the logical relationships among different concepts. This pa- per divides TCM market into two stages as Chinese materia medica resource market and traditional Chinese Patent Medicines market. Under this foundation, we investigated the supply capacity, approaching rules and motivation system of suppliers in TCM market, ana- lyzed the demand situation in the perspective of demand side, and evaluated the purchasing power in terms of population profile, in- come, and insurance. Furthermore we also analyzed the price formation mechanism in two stages of TCM market. We hope this study can make a positive and promotion effect on TCM market related research.
出处 《中国中药杂志》 CAS CSCD 北大核心 2014年第2期328-333,共6页 China Journal of Chinese Materia Medica
基金 国家自然科学基金项目(81130070 81072989) 国家科技支撑计划项目(2012BAI29B02 2012BAI28B002)
关键词 中药资源市场 中药药品市场 购买力 供给方 价格机制 Chinese material medica resource market traditional Chinese patent medicines market purchasing power sup- plier price mechanism
  • 相关文献

参考文献7

  • 1Mark V Pauly, Thomas G Mcguire, Pedro P Barros. Handbook of health economic [ M ]. US : North-Holland, 2012 : 772.
  • 2国家统计局.中国统计年鉴.1995-2012年[DB/OL].ht.tp://www.stats.gov.cn/cjsj/ndsj/.
  • 3Thomas E Getzen. Health care is an individual necessity and a national luxury: applying multilevel decision models to the analy- sis of health care expenditures [ J. J Health Econ,2000 (19) : 259.
  • 4Krupa Subramanian, Jean Lemaire, John C Hershey, et al. Esti- mating adverse selection costs from genetic testing for breast and ovarian cancer: the case of life insurance [ J ] . J Risk Insur, 1999, 66(4) :531.
  • 5Mark J Browne. Evidence of adverse selection in the individual health insurance market [ J ]. J Risk Insur, 1992, 59 (1) :13.
  • 6Jay Bhattaeharya, Mikko Packalen. The other exante moral haz- ard in health[J]. J Health Eeon,2012, 31(1) :135.
  • 7张伯伦.垄断竞争理论[M].北京:华夏出版社,2009:59.

共引文献2

同被引文献152

引证文献7

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部